Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy.

Cancer medicine·2026
Same author

Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911.

International journal of radiation oncology, biology, physics·2025
Same author

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.

Journal for immunotherapy of cancer·2023
Same author

Trends in Adjuvant Therapy After Surgery for Oropharyngeal Squamous Cell Carcinoma.

The Laryngoscope·2021
Same author

Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base.

Journal of neurological surgery reports·2019
Same author

Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

Journal of neuro-oncology·2018
Same journal

Guar Gum, Partially Hydrolyzed Guar Gum, and Human Gut Health: A Narrative Review.

Reviews on recent clinical trials·2026
Same journal

The Gut Microbiota: A Functional Hub Linking Nutrition, Immunity, and Cardiovascular Health.

Reviews on recent clinical trials·2026
Same journal

Rupture of Renal Pelvis: A Case Report and Literature Review of a Rare Complication of Ureteral Lithiasis.

Reviews on recent clinical trials·2026
Same journal

Comparison between Tightrope and Hook Plate Techniques in the Treatment of Acromioclavicular Joint Dislocations: A Systematic Review and Meta-Analysis.

Reviews on recent clinical trials·2026
Same journal

Cerebral Air Embolism after Small-bore Chest Tube Insertion in a Patient with Hydropneumothorax: A Case Report.

Reviews on recent clinical trials·2026
Same journal

Pharmacological Interventions in Primary Amoebic Meningoencephalitis: Clinical Challenges and Strategic Solutions.

Reviews on recent clinical trials·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Accelerated partial breast irradiation- pros and cons.

Voichita Bar Ad1

  • 1Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA. barad@uphs.upenn.edu

Reviews on Recent Clinical Trials
|September 28, 2010
PubMed
Summary
This summary is machine-generated.

Accelerated partial breast irradiation (APBI) may offer a shorter treatment for early breast cancer, potentially improving patient convenience. However, careful patient selection and defined guidelines are crucial to balance benefits against recurrence risks and toxicity.

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Related Experiment Videos

Last Updated: Jun 8, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Whole breast irradiation is standard for early breast cancer, offering good outcomes.
  • In-breast recurrences often originate near the primary tumor site.

Purpose of the Study:

  • To evaluate accelerated partial breast irradiation (APBI) as an alternative to whole breast irradiation for select early breast cancer patients.
  • To explore the potential benefits and risks of APBI, including treatment duration and toxicity.

Main Methods:

  • This study reviews the current understanding and preliminary results of APBI.
  • It discusses the hypothesis that APBI may be sufficient for selected patients.

Main Results:

  • APBI offers a shorter treatment schedule, potentially increasing patient convenience and breast conservation rates.
  • Preliminary results for APBI are encouraging.

Conclusions:

  • APBI shows promise for selected early breast cancer patients, potentially reducing treatment time.
  • Further research is needed to define optimal patient selection criteria and dosimetric guidelines for APBI to mitigate risks.